The chief executive and chief medical officers of Celyad Oncology discussed the company’s future research and plans.
Filippo Petti
Advertisement
Chief Executive Officer, Celyad Oncology
Articles by Filippo Petti
The chief executive and chief medical officers of Celyad Oncology discussed their platform and positive data presented at EHA 2021.
The chief executive and chief medical officer of Celyad Oncology discussed the advantages of allogeneic CAR T therapies over autologous ones.
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on CGTlive®
1
CARsgen’s CAR-T Satri-Cel Significantly Reduces CA19-9 Levels in Patients With Pancreatic Ductal Adenocarcinoma
2
Around the Helix: Cell and Gene Therapy Company Updates – October 22, 2025
3
Guess the Therapy Answer October 23, 2025
4
